Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Auditor change
Acq. announced
Quarterly results

ONCOSEC MEDICAL Inc (ONCS) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/10/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
06/02/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
05/26/2023 D Form D - Notice of Exempt Offering of Securities:
05/25/2023 SC 13G INTRACOASTAL CAPITAL, LLC reports a 5% stake in OncoSec Medical Incorporated
05/19/2023 SC 13G SZOP Multistrat Management LLC reports a 5.6% stake in Oncosec Medical Incorporated
05/18/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "COMMON STOCK PURCHASE WARRANT ONCOSEC MEDICAL INCORPORATED Warrant Shares: _______ Issue Date: __________, 2023 Initial Exercise Date: _____________, 2023 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on _______ [1] but not thereafter, to subscribe for and purchase from OncoSec Medical Incorporated, a Nevada corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized terms used and not otherwi...",
"PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT ONCOSEC MEDICAL INCORPORATED Warrant Shares: _______ Issue Date: May 18, 2023 Initial Exercise Date: May 18, 2023 THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on May 16, 2028 but not thereafter, to subscribe for and purchase from OncoSec Medical Incorporated, a Nevada corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. This Warrant is being issued pursuant to t...",
"Letter re: Registration Statement on Form S-3",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of May 16, 2023, between OncoSec Medical Incorporated, a Nevada corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act , as to the Shares, the Prefunded Warrants and Prefunded Warrant Shares and an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4 thereof and/or Regulation D promulgated thereunder as to the Common Warrants, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as mo...",
"Investor Contact",
"Investor Contact"
05/18/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/16/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact"
04/27/2023 8-K Quarterly results
04/24/2023 D Form D - Notice of Exempt Offering of Securities:
04/17/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/03/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
04/03/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact"
03/27/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
02/28/2023 RW Form RW - Registration Withdrawal Request:
02/22/2023 8-K Other Events  Interactive Data
02/14/2023 SC 13G/A Avidity Partners Management LP reports a 0% stake in Oncosec Medical Incorporated
02/01/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
01/04/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
12/28/2022 8-K Quarterly results
12/27/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/15/2022 10-Q Quarterly Report for the period ended October 31, 2022
12/12/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
12/02/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
12/01/2022 8-K Quarterly results
12/01/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/01/2022 EFFECT Form EFFECT - Notice of Effectiveness:
11/29/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
11/29/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "ONCOSEC MEDICAL INCORPORATED Convertible Promissory Note and Security Agreement due November 25, 2024 Dated: November 25, 2022 $2,000,000.00 For value received, ONCOSEC MEDICAL INCORPORATED, a Nevada corporation , hereby promises to pay to the order of Grand Decade Developments Limited, a British Virgin Islands limited company and a wholly owned subsidiary of Grand Pharmaceutical Group Limited , in accordance with the terms hereinafter provided, the principal amount of $2 million together with interest thereon. All payments under or pursuant to this Note or the other Transaction Documents shall be made in United States Dollars in immediately available funds by wire transfer of funds to the Holder’ s account, instructions for which are set forth on Exhibit A . The outstanding principal bal..."
11/28/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
11/23/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
11/22/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
11/15/2022 8-K Quarterly results
11/14/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy